Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Active Crohn's Disease
NCT02199561Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jul 2014
- Primary completion
- Dec 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Crohn's disease, sponsored by University of Alberta. Started Jul 2014; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02199561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199561.